Colin Osborne
NovaBay Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Wound Healing and Treatments, Antibiotics Pharmacokinetics and Efficacy
Most-Cited Works
- → Amino Acid Substitution inTrichophyton rubrumSqualene Epoxidase Associated with Resistance to Terbinafine(2005)149 cited
- → Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection(2012)116 cited
- → Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)(2011)94 cited
- → Biological, Biochemical, and Molecular Characterization of a New Clinical Trichophyton rubrum Isolate Resistant to Terbinafine(2006)89 cited
- → NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models(2021)84 cited
- → Investigation into the tensile properties of collagen/chondroitin-6-sulphate gels: the effect of crosslinking agents and diamines(1998)69 cited
- → Investigation into the biological stability of collagen/chondroitin-6-sulphate gels and their contraction by fibroblasts and keratinocytes: the effect of crosslinking agents and diamines(1999)60 cited
- → Design, Synthesis, and Properties of a Potent Inhibitor ofPseudomonas aeruginosaDeacetylase LpxC(2017)45 cited
- → Antifungal drug response in anin vitromodel of dermatophyte nail infection(2004)42 cited
- → Antibacterial Optimization of 4-Aminothiazolyl Analogues of the Natural Product GE2270 A: Identification of the Cycloalkylcarboxylic Acids(2011)41 cited